Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Jones

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
American Journal of Surgery|July 13, 2024
Marijuana may lead to increased platelet activity in trauma patientsDanielle F Tanner, Joel G Eastes, Emily A Reeson, et al.
Nature Chemical Biology|June 19, 2019
Harnessing the anti-cancer natural product nimbolide for targeted protein degradationJessica N Spradlin, Xirui Hu, Carl C Ward, et al.
Journal of Human Genetics|October 7, 2016
The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United StatesHemakumar M Reddy, Kyung-Ah Cho, Monkol Lek, et al.
Nature Medicine|December 19, 2018
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR lossHuayang Liu, Javad Golji, Lauren K Brodeur, et al.
Physiological Genomics|October 23, 2018
Impact of PYROXD1 deficiency on cellular respiration and correlations with genetic analyses of limb-girdle muscular dystrophy in Saudi Arabia and SudanMadhurima Saha, Hemakumar M Reddy, Mustafa A Salih, et al.
Cancer Discovery|June 5, 2016
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic RegionsDiana M Munoz, Pamela J Cassiani, Li Li, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1Julian R Levell, Thomas Caferro, Gregg Chenail, et al.
ACS Chemical Biology|April 2, 2024
Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening ProfilesJason R Thomas, Claude Shelton, Jason Murphy, et al.
Langenbeck'S Archives of Surgery|March 26, 2016
Characteristics of contralateral carcinomas in patients with differentiated thyroid cancer larger than 1 cmLutske Lodewijk, Wouter P Kluijfhout, Jakob W Kist, et al.
Nature|December 19, 2018
Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
American Journal of Surgery|July 13, 2024
Marijuana may lead to increased platelet activity in trauma patientsDanielle F Tanner, Joel G Eastes, Emily A Reeson, et al.
Nature Chemical Biology|June 19, 2019
Harnessing the anti-cancer natural product nimbolide for targeted protein degradationJessica N Spradlin, Xirui Hu, Carl C Ward, et al.
Journal of Human Genetics|October 7, 2016
The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United StatesHemakumar M Reddy, Kyung-Ah Cho, Monkol Lek, et al.
Nature Medicine|December 19, 2018
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR lossHuayang Liu, Javad Golji, Lauren K Brodeur, et al.
Physiological Genomics|October 23, 2018
Impact of PYROXD1 deficiency on cellular respiration and correlations with genetic analyses of limb-girdle muscular dystrophy in Saudi Arabia and SudanMadhurima Saha, Hemakumar M Reddy, Mustafa A Salih, et al.
Cancer Discovery|June 5, 2016
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic RegionsDiana M Munoz, Pamela J Cassiani, Li Li, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1Julian R Levell, Thomas Caferro, Gregg Chenail, et al.
ACS Chemical Biology|April 2, 2024
Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening ProfilesJason R Thomas, Claude Shelton, Jason Murphy, et al.
Langenbeck'S Archives of Surgery|March 26, 2016
Characteristics of contralateral carcinomas in patients with differentiated thyroid cancer larger than 1 cmLutske Lodewijk, Wouter P Kluijfhout, Jakob W Kist, et al.
Nature|December 19, 2018
Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityJordi Barretina, Giordano Caponigro, Nicolas Stransky, et al.
Pageof 10